From The Stage

[EPISODE 6] Dr. Laura Sepp-Lorenzino Talks Gene Editing, Mentorships, and Making Big Moves!

Posted by BioAgilytix / /

In today’s episode, Chad sits down with guest scientist, Dr. Laura Sepp-Lorenzino the Chief Scientific Officer at Intellia Therapeutics. Laura is an innovative leader in drug discovery and the development of small molecules and nucleotide therapeutics. Pharma is in Laura’s blood as her mother, a pharmacist, encouraged her to pursue a career in the science. She shares how she went from studying biochemistry in Argentina and her pursuit of a Ph.D., then pivoting in a life-changing move to the United States. She also talks about the importance of paying it…

Taking Risks and Setting Precedent in Bioanalytical Assays for Cell & Gene Therapies

Posted by BioAgilytix / /

There are no bad ideas in developing bioanalytical testing, says Jim McNally, CSO of BioAgilytix. Not all ideas will work, of course. But he has found that it is the outside-the-box ideas that often turn out to be the solution in challenging assay work. Dr. McNally speaks with The Chain about his background in bioanalytical testing and supporting clinical trials, the exciting future of cell and gene therapies, and the importance of setting precedent in bioanalysis of these new, life-saving therapies. It is an exciting time for gene therapy especially,…

[EPISODE 5] Dr. Tina Morris Talks Photography, Bioanalytics, and Leadership!

Posted by BioAgilytix / /

In today’s episode, Chad sits down with guest scientist, Dr. Tina Morris the executive director of the AAPS. Tina has a distinguished career in the pharmaceutical industry including senior leadership roles at US Pharmacopia, Parenteral Drug Association, and the AAPS. She helps us understand the importance of these industry organizations and how we can make a difference by getting involved. She brings real credibility as a scientist in her leadership roles as we hear about her experiences as a senior-level scientist at Ciphergen and Human Genome Sciences. They also talk…

BioAgilytix Is Re-approved and Registered For The French Research Tax Credit (CIR)

Posted by BioAgilytix / /

HAMBURG, GERMANY: Jan 13, 2021 – BioAgilytix is thrilled to announce that our European lab in Hamburg, Germany is now CIR approved for 2020, 2021 and 2022, which allows us to provide fiscal support to French sponsors. The Research Tax Credit (CIR) is a tax incentive that is designed to encourage company research and development efforts by deducting expenses associated with R&D from a company’s taxes. In an effort to provide an innovative and financially advantageous environment for industries to thrive, France boasts one of the most competitive tax exemptions…

TBJ Covers 2021 People to Watch: BioAgilytix CEO Jim Datin

Posted by BioAgilytix / /

In this news article, TBJ covers in depth the history and achievements of BioAgilytix’ CEO, Jim Datin. He has been at the helm of BioAgilytix since November 2013 and has put BioAgilytix on the path of growth and expansion.